291 related articles for article (PubMed ID: 11843819)
1. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
[TBL] [Abstract][Full Text] [Related]
2. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
[TBL] [Abstract][Full Text] [Related]
3. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
Hamblin TJ; Orchard JA; Ibbotson RE; Davis Z; Thomas PW; Stevenson FK; Oscier DG
Blood; 2002 Feb; 99(3):1023-9. PubMed ID: 11807008
[TBL] [Abstract][Full Text] [Related]
4. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U
Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260
[TBL] [Abstract][Full Text] [Related]
5. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia.
Lin K; Sherrington PD; Dennis M; Matrai Z; Cawley JC; Pettitt AR
Blood; 2002 Aug; 100(4):1404-9. PubMed ID: 12149224
[TBL] [Abstract][Full Text] [Related]
6. CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia.
Thunberg U; Johnson A; Roos G; Thörn I; Tobin G; Sällström J; Sundström C; Rosenquist R
Blood; 2001 Mar; 97(6):1892-4. PubMed ID: 11263438
[No Abstract] [Full Text] [Related]
7. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
[TBL] [Abstract][Full Text] [Related]
8. CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia.
Matrai Z; Lin K; Dennis M; Sherrington P; Zuzel M; Pettitt AR; Cawley JC
Blood; 2001 Mar; 97(6):1902-3. PubMed ID: 11263445
[No Abstract] [Full Text] [Related]
9. Immunoglobulin V genes and CD38 expression in CLL.
Hamblin TJ; Orchard JA; Gardiner A; Oscier DG; Davis Z; Stevenson FK
Blood; 2000 Apr; 95(7):2455-7. PubMed ID: 10787241
[No Abstract] [Full Text] [Related]
10. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.
Oscier DG; Gardiner AC; Mould SJ; Glide S; Davis ZA; Ibbotson RE; Corcoran MM; Chapman RM; Thomas PW; Copplestone JA; Orchard JA; Hamblin TJ
Blood; 2002 Aug; 100(4):1177-84. PubMed ID: 12149195
[TBL] [Abstract][Full Text] [Related]
11. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.
Chevallier P; Penther D; Avet-Loiseau H; Robillard N; Ifrah N; Mahé B; Hamidou M; Maisonneuve H; Moreau P; Jardel H; Harousseau JL; Bataille R; Garand R
Br J Haematol; 2002 Jan; 116(1):142-50. PubMed ID: 11841407
[TBL] [Abstract][Full Text] [Related]
12. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
[TBL] [Abstract][Full Text] [Related]
14. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.
Damle RN; Wasil T; Fais F; Ghiotto F; Valetto A; Allen SL; Buchbinder A; Budman D; Dittmar K; Kolitz J; Lichtman SM; Schulman P; Vinciguerra VP; Rai KR; Ferrarini M; Chiorazzi N
Blood; 1999 Sep; 94(6):1840-7. PubMed ID: 10477712
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia.
Hsi ED; Kopecky KJ; Appelbaum FR; Boldt D; Frey T; Loftus M; Hussein MA
Br J Haematol; 2003 Mar; 120(6):1017-25. PubMed ID: 12648072
[TBL] [Abstract][Full Text] [Related]
16. Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia.
Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
Eur J Haematol; 2003 Jan; 70(1):53-9. PubMed ID: 12631259
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
[TBL] [Abstract][Full Text] [Related]
18. Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.
Tinhofer I; Weiss L; Gassner F; Rubenzer G; Holler C; Greil R
J Immunother; 2009 Apr; 32(3):302-9. PubMed ID: 19242370
[TBL] [Abstract][Full Text] [Related]
19. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]